Physician profile
Jennifer Wright
NPI 1831557149
$5,647.34
in general payments reported to CMS, 2019-2025
49 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,074 · 2022: $936 · 2023: $1,064 · 2024: $1,155 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,637.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $734.66 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $508.83 | 2021-2025 | Rexulti, Nuedexta |
| Amgen INC. | $461.84 | 2021-2025 | Repatha, Otezla, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $421.84 | 2021-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $341.67 | 2022-2025 | |
| Lundbeck LLC | $321.04 | 2023-2025 | Vyepti, Rexulti |
| Pfizer INC. | $225.54 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $206.50 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $195.32 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Takeda Pharmaceuticals U.S.A., INC. | $193.54 | 2021-2025 | Hyqvia, Trintellix |
| Daiichi Sankyo INC. | $179.37 | 2021-2025 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.52 | 2021-2023 | Synjardy, Tradjenta, Jardiance |
| Novo Nordisk INC | $139.40 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Nestle Healthcare Nutrition INC. | $136.50 | 2021-2022 | |
| Eisai INC. | $128.19 | 2024-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $125.36 | 2024-2025 | Rystiggo, Fintepla |
| Lilly USA, LLC | $120.77 | 2022-2025 | Jardiance, Mounjaro, Kisunla |
| Argenx US, INC. | $110.33 | 2024-2025 | Vyvgart Hytrulo |
| Biohaven Pharmaceutical Holding Company LTD. | $89.78 | 2022 | |
| Glaxosmithkline, LLC. | $83.33 | 2021-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $60.97 | 2023-2025 | Cologuard Collection Kit |
| Tg Therapeutics, INC. | $59.19 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $51.96 | 2021 | |
| Corcept Therapeutics | $50.36 | 2024-2025 | Korlym |
| Sk Life Science, INC. | $49.32 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $34.58 | 2023 | Austedo Xr, Ajovy |
| Innocoll Pharmaceuticals Limited | $33.85 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.13 | 2021 | |
| Medtronic, INC. | $31.56 | 2021 | |
| Esperion Therapeutics, INC. | $31.43 | 2021 | |
| Vanda Pharmaceuticals INC. | $27.35 | 2021 | |
| Antares Pharma, INC. | $26.92 | 2021 | |
| Alkermes, INC. | $25.53 | 2023 | Vivitrol |
| Irhythm Technologies, INC. | $23.89 | 2022 | |
| Livanova USA, INC. | $23.78 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Csl Behring | $23.39 | 2025 | Hizentra |
| Acadia Pharmaceuticals INC | $19.80 | 2025 | Nuplazid |
| Supernus Pharmaceuticals, INC. | $19.19 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.23 | 2023 | Ultomiris |
| Access Pro Medical, LLC | $17.76 | 2022 | |
| Merck Sharp & Dohme LLC | $17.59 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $16.69 | 2024 | Spravato |
| Seqirus USA INC | $15.82 | 2025 | Flucelvax, Fluad |
| C2n Diagnostics, LLC | $14.25 | 2025 | Precivityad2 |
| Hologic Sales and Service, LLC | $13.84 | 2021 | |
| Phathom Pharmaceuticals, INC. | $13.02 | 2025 | Voquezna |
| Sanofi Pasteur INC. | $12.72 | 2022 | |
| Dynavax Technologies Corporation | $11.79 | 2023 | Heplisav-B |
| Organon LLC | $4.10 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.